The European Commission has published the Horizon Europe Work Programmes for 2026–2027, confirming EUR 14 billion in EU investment to support research and innovation across Europe over the next two years. In line with the EUDA mandate (1), we have reviewed the programmes and identified a set of upcoming Horizon Europe calls of relevance to drug-related research and innovation. These calls span multiple parts of the programme, including:
Cluster 1: Health — addressing prevention, mental health, non-communicable diseases and health systems.
Cluster 3: Civil Security for Society — including…